Table 1. SERPING1 variants identified by DNA sequencing or multiplex ligation-dependent probe amplification.
cDNA numbering | Localization | Protein effect | Classification● | Type of mutation | C1-INH-HAE type | No. of families | Reference | |
---|---|---|---|---|---|---|---|---|
1 | c.19dupC | Exon 2 | p.Leu7Profs*13 | Likely pathogenic | Small dup | I | 1 | Novel |
2 | c.124G>T | Exon 3 | p.Glu42* | Pathogenic | Nonsense | I | 2 | Pappalardo [16] |
3 | c.310C>T | Exon 3 | p.Gln104* | Likely pathogenic | Nonsense | I | 1 | Gösswein [23] |
4 | c.360delG | Exon 3 | p.Ser121Profs*27 | Likely pathogenic | Small del | I | 1 | Novel |
5 | c.550G>A | Exon 3 | p.Gly184Arg or splicing | Pathogenic | Missense/Splice defect | I | 2 | Kesim [24] Verpy [25] Bygum [13] |
6 | c.695T>G | Exon 5 | p.Ile232Arg | Likely pathogenic | Missense | I | 1 | Novel |
7 | c.889+3A>T | Intron 5 | p.Asp229_Ser296del | Likely pathogenic | Splice defect, skipping of exon 5 | I | 1 | Novel |
8 | c.1232C>G | Exon 7 | p.Ser411* | Pathogenic | Nonsense | I | 2 | Novel |
9 | c.1297delG | Exon 8 | p.Asp433Thrfs*17 | Likely pathogenic | Small del | I | 1 | Novel |
10 | c.1396C>T | Exon 8 | p.Arg466Cys | Pathogenic | Missense | II | 6 | Skriver [18] Freiberger [26] Stein [27] Kalmar [28] |
Deletions | ||||||||
11 | del exon 1–4 (a) | Pathogenic | Gross deletion | I | 1 | Duponchel [29] | ||
12 | del exon 1–8 (b) | Pathogenic | Gross deletion | I | 1 | Duponchel [29] | ||
13 | del entire or part of exon 4 | Pathogenic | Gross deletion | I | 2 | Duponchel [29] Gösswein [23] Verpy [20] |
(a) The upstream breakpoint for the deletion is located less than 364kb from exon 1. Downstream breakpoint is probably located within intron 4.
(b) The upstream breakpoint for the deletion is located less than 364kb from exon 1. Downstream breakpoint is unknown.
● Criteria for classification:
Likely pathogenic:
- nonsense mutations or out of frame indels.
- missense mutations previously reported in two families.
Pathogenic:
- nonsense mutations or out of frame indels previously reported.
- missense mutations previously reported in more than two families.